Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
DaVita (DVA)
NYSE:DVA
DaVita (DVA) Stock Price & Analysis
881 Followers
DVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$71.51 - $147.93
Previous Close$138.61
Volume680.78K
Average Volume (3M)862.29K
Market Cap
$12.16B
Enterprise Value$24.57B
Total Cash (Recent Filing)$391.67M
Total Debt (Recent Filing)$11.12B
Price to Earnings (P/E)15.7
Beta0.41
Next Earnings
Aug 01, 2024EPS Estimate
$2.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.81
Shares Outstanding87,700,000
10 Day Avg. Volume1,266,050
30 Day Avg. Volume862,293
Standard Deviation0.10
R-Squared0.25
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-1.98
Price to Sales (P/S)1.02
Price to Cash Flow (P/CF)6.40
P/FCF Ratio8.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.02
Enterprise Value/Gross Profit6.43
Enterprise Value/Ebitda11.61
Forecast
1Y Price Target
$146.33Price Target Upside5.69% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
DaVita News
Bulls Say, Bears Say
Bulls Say
EarningsDVA raised the adjusted operating income guidance by $50 million at the low end as pricing in the quarter came in better versus internal expectations.
Financial PerformanceDVA has seen an improvement in revenue per treatment growth due to higher inflation flowing through to Medicare rates and commercial repricing.
Operational EfficiencyImproving capacity utilization is a large lever to better margins, and DVA has closed or consolidated sites to improve margins.
Bears Say
Financial PerformanceEstimated loss of $37m of EBITDA in 2025 for DaVita Inc. due to the new CMS rates.
Geographic PerformanceNorth America saw only a 2% benefit versus the placebo group, whereas Europe (39%) and Other geographies recorded significantly higher benefits that drove headline results.
Regulatory ImpactProposed CMS rate increase for dialysis clinics of 3.12% significantly reduced to a final rate of 1.76%.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DVA FAQ
What was DaVita’s price range in the past 12 months?
DaVita lowest stock price was $71.51 and its highest was $147.93 in the past 12 months.
What is DaVita’s market cap?
Currently, no data Available
When is DaVita’s upcoming earnings report date?
DaVita’s upcoming earnings report date is Aug 01, 2024 which is in 29 days.
How were DaVita’s earnings last quarter?
DaVita released its earnings results on May 02, 2024. The company reported $2.38 earnings per share for the quarter, beating the consensus estimate of $1.948 by $0.432.
Is DaVita overvalued?
According to Wall Street analysts DaVita’s price is currently Undervalued.
Does DaVita pay dividends?
DaVita does not currently pay dividends.
What is DaVita’s EPS estimate?
DaVita’s EPS estimate is $2.55.
How many shares outstanding does DaVita have?
DaVita has 87,700,000 shares outstanding.
What happened to DaVita’s price movement after its last earnings report?
DaVita reported an EPS of $2.38 in its last earnings report, beating expectations of $1.948. Following the earnings report the stock price went down -5.477%.
Which hedge fund is a major shareholder of DaVita?
Among the largest hedge funds holding DaVita’s share is Berkshire Hathaway Inc. It holds DaVita’s shares valued at 5B.
---
DaVita Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$146.33 (5.69% Upside)
$146.33 (5.69% Upside)
Blogger Sentiment
Bullish
DVA Sentiment 87%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 454.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $698.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.96%
12-Months-Change
Fundamentals
Return on Equity
93.14%
Trailing 12-Months
Asset Growth
4.20%
Trailing 12-Months
Company Description
DaVita
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
---
DVA Earnings Call
Q1 2024
0:00 / 0:00
---
DVA Revenue Breakdown
95.34% U.S. dialysis
4.66% Ancillary services
---
DVA Stock 12 Month Forecast
Average Price Target
$146.33
▲(5.69% Upside)
Technical Analysis
Best Analysts Covering DVA
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-35.05%
reiterated a sell rating 2 months ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.05% per trade.
---